Form D · Biotechnology
10408875 Canada Inc.
Montreal, A8 · CIK 0001787926
Offering snapshot reported Sep 12, 2019 · SEC filing
- Reported sold
- $402K Offering amount: $1.23M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 12, 2019 | Initial | $402,255 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-348636
Source: Form D, filed Sep 12, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Milad Dagher | Director, Executive |
| Arya Tavakoli | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
51 Sherbrooke West, Suite 106
Montreal, A8, H2X 1X2
Montreal, A8, H2X 1X2